Chantal Raymond | 27/03/2024
It is safe to say that research provides better quality of life and will lead, one day, inevitably to cures. This is why the Canadian Hemophilia Society (CHS) is...
David Page | 26/03/2024
Montreal, March 26, 2024 – Developments in gene therapy for hemophilia B have come fast and furious over the last several months. In October 2023, Health Canada approved CSL...
David Page | 22/01/2024
Hamilton, January 22, 2024 – McMaster University, in collaboration with CSL Behring, has announced a new gene therapy trial for etranacogene dezaparvovec (Hemgenix) in hemophilia B. Hemgenix received its...
Chantal Raymond | 27/11/2023
The hemophilia community has been waiting for gene therapy for years; many hoped it would be a cure. Quantitative and qualitative results from late stages of clinical trials for...